See What is Missing: Why LUMA GC has a place in Pharmaceutical Development and Manufacture
Webinar Date/Time: Thu, Sep 26, 2024 11:00 AM EDT
Explore the innovative application of VUV Analytics' LUMA™ GC detector in analyzing complex pharmaceutical mixtures.
Register Free:
https://www.chromatographyonline.com/lcgc_w/what-is-missing
Event Overview:
In the field of pharmaceutical process development and manufacture, the need for fast, cheap, accurate and reliable analytical techniques remains key. This webcast explores the innovative application of VUV Analytics' LUMA GC Detector in analysing complex pharmaceutical mixtures, with a focus on advancing key areas such as peak deconvolution, impurity detection, and FID invisible targets such as water content.
This webcast will explore how data from LUMA effectively complements traditional detection methods such as FID, particularly in tracking reaction progress, analysing low-level impurities (including challenging species such as Genotoxic impurities), and assessing water content at various stages of drug synthesis. Real-world examples will illustrate scenarios where Luma offers distinct advantages to conventional methods, with enhanced detection capabilities and resolving challenging separations.
Attendees will gain insights into LUMA’s unique spectral capabilities for method development, ensuring greater accuracy and confidence in their analytical workflows. Additionally, we will discuss practical considerations for water determination using Luma, addressing common challenges and showcasing its potential for broader applications.
Key Learning Objectives:
- Understand how LUMA and its unique spectral capabilities address challenges in pharmaceutical method development.
- Understand the practical considerations for moisture determination using LUMA.
- Gain a better scope of the potential broader applications that can be addressed using LUMA.
Who Should Attend:
- Lab Managers
- Method Development Chemists
- Process Chemists
- Director of Analytical Technology
Speaker:
Sam Whitmarsh
Director of Analytical Science
Catsci
Sam Whitmarsh has 20 years of R&D experience at AstraZeneca, BP, and CatSci. After completing his PhD at the University of Bristol, he held roles in analytical science at AstraZeneca, founded BP's UK mass spectrometry facility, and led the BP Global Analytical Science Network. Sam joined CatSci as head of scientific operations in 2020 and became Director of Analytical Science and Digital Transformation in 2022. Sam is a Royal Society of Chemistry Fellow serving with the Separation Science (SSG) and Chemical Information and Computer Applications (CICAG) interest groups.
Register Free:
https://www.chromatographyonline.com/lcgc_w/what-is-missing
University of Rouen-Normandy Scientists Explore Eco-Friendly Sampling Approach for GC-HRMS
April 17th 2025Root exudates—substances secreted by living plant roots—are challenging to sample, as they are typically extracted using artificial devices and can vary widely in both quantity and composition across plant species.
Miniaturized GC–MS Method for BVOC Analysis of Spanish Trees
April 16th 2025University of Valladolid scientists used a miniaturized method for analyzing biogenic volatile organic compounds (BVOCs) emitted by tree species, using headspace solid-phase microextraction coupled with gas chromatography and quadrupole time-of-flight mass spectrometry (HS-SPME-GC–QTOF-MS) has been developed.
Fundamentals of Benchtop GC–MS Data Analysis and Terminology
April 5th 2025In this installment, we will review the fundamental terminology and data analysis principles in benchtop GC–MS. We will compare the three modes of analysis—full scan, extracted ion chromatograms, and selected ion monitoring—and see how each is used for quantitative and quantitative analysis.
